These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37744900)

  • 1. A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.
    Bose T; Wasimuddin ; Acharya V; Pinna NK; Kaur H; Ranjan M; SaiKrishna J; Nagabandi T; Varma B; Tallapaka KB; Sowpati DT; Haque MM; Dutta A; Siva AB; Mande SS
    Front Microbiol; 2023; 14():1238829. PubMed ID: 37744900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types.
    Gupta A; Karyakarte R; Joshi S; Das R; Jani K; Shouche Y; Sharma A
    Microbes Infect; 2022 Feb; 24(1):104880. PubMed ID: 34425246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasopharyngeal microbiota profiling of pregnant women with SARS-CoV-2 infection.
    Crovetto F; Selma-Royo M; Crispi F; Carbonetto B; Pascal R; Larroya M; Casas I; Tortajada M; Escudero N; Muñoz-Almagro C; Gomez-Roig MD; González-Torres P; Collado MC; Gratacos E
    Sci Rep; 2022 Aug; 12(1):13404. PubMed ID: 35927569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity.
    Gauthier NPG; Locher K; MacDonald C; Chorlton SD; Charles M; Manges AR
    PLoS One; 2022; 17(10):e0275815. PubMed ID: 36240246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity.
    Kim JG; Zhang A; Rauseo AM; Goss CW; Mudd PA; O'Halloran JA; Wang L
    J Med Virol; 2023 Feb; 95(2):e28445. PubMed ID: 36583481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the nasopharyngeal microbiome and respiratory pathogens in COVID-19 patients from Saudi Arabia.
    Yasir M; Al-Sharif HA; Al-Subhi T; Sindi AA; Bokhary DH; El-Daly MM; Alosaimi B; Hamed ME; Karim AM; Hassan AM; AlShawdari MM; Alawi M; El-Kafrawy SA; Azhar EI
    J Infect Public Health; 2023 May; 16(5):680-688. PubMed ID: 36934642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.
    Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J
    mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to
    Nardelli C; Gentile I; Setaro M; Di Domenico C; Pinchera B; Buonomo AR; Zappulo E; Scotto R; Scaglione GL; Castaldo G; Capoluongo E
    Front Cell Infect Microbiol; 2021; 11():625581. PubMed ID: 33659220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy.
    Giugliano R; Sellitto A; Ferravante C; Rocco T; D'Agostino Y; Alexandrova E; Lamberti J; Palumbo D; Galdiero M; Vaccaro E; Pagliano P; Weisz A; Giurato G; Franci G; Rizzo F
    Microb Pathog; 2022 Apr; 165():105506. PubMed ID: 35358660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nasopharyngeal microbiome in COVID-19.
    Candel S; Tyrkalska SD; Álvarez-Santacruz C; Mulero V
    Emerg Microbes Infect; 2023 Dec; 12(1):e2165970. PubMed ID: 36606725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasopharyngeal microbiome of COVID-19 patients revealed a distinct bacterial profile in deceased and recovered individuals.
    Kumar D; Pandit R; Sharma S; Raval J; Patel Z; Joshi M; Joshi CG
    Microb Pathog; 2022 Dec; 173(Pt A):105829. PubMed ID: 36252893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 16S rRNA gene sequencing data of the upper respiratory tract microbiome in the SARS-CoV-2 infected patients.
    Galeeva J; Babenko V; Bakhtyev R; Baklaushev V; Balykova L; Bashkirov P; Bespyatykh J; Blagonravova A; Boldyreva D; Fedorov D; Gafurov I; Gaifullina R; Galova E; Gospodaryk A; Ilina E; Ivanov K; Kharlampieva D; Khromova P; Klimina K; Kolontarev K; Kolyshkina N; Koritsky A; Kuropatkin V; Lazarev V; Manolov A; Manuvera V; Matyushkina D; Morozov M; Moskaleva E; Musarova V; Ogarkov O; Orlova E; Pavlenko A; Petrova A; Pozhenko N; Pushkar D; Rumyantsev A; Rumyantsev S; Rumyantsev V; Rychkova L; Samoilov A; Shirokova I; Sinkov V; Solovieva S; Starikova E; Tikhonova P; Trifonova G; Troitsky A; Tulichev A; Udalov Y; Varizhuk A; Vasiliev A; Veselovsky V; Vereshchagin R; Volnukhin A; Yusubalieva G; Govorun V
    Data Brief; 2022 Feb; 40():107770. PubMed ID: 34977286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
    Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J
    Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients.
    Engen PA; Naqib A; Jennings C; Green SJ; Landay A; Keshavarzian A; Voigt RM
    Biol Proced Online; 2021 Jun; 23(1):10. PubMed ID: 34058978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 alters human microbiomes: a meta-analysis.
    Reuben RC; Beugnon R; Jurburg SD
    Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19.
    Ventero MP; Cuadrat RRC; Vidal I; Andrade BGN; Molina-Pardines C; Haro-Moreno JM; Coutinho FH; Merino E; Regitano LCA; Silveira CB; Afli H; López-Pérez M; Rodríguez JC
    Front Microbiol; 2021; 12():637430. PubMed ID: 33815323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021.
    Laxmaiah A; Rao NM; Arlappa N; Babu J; Kumar PU; Singh P; Sharma D; Anumalla VM; Kumar TS; Sabarinathan R; Kumar MS; Ananthan R; Basha DA; Blessy PPS; Kumar DC; Devaraj P; Devendra S; Kumar MM; Meshram II; Kumar BN; Sharma P; Raghavendra P; Raghu P; Rao KR; Ravindranadh P; Kumar BS; Sarika G; Rao JS; Surekha MV; Sylvia F; Kumar D; Rao GS; Tallapaka KB; Sowpati DT; Srivastava S; Murhekar VM; Hemalatha R; Mishra RK
    IJID Reg; 2022 Mar; 2():1-7. PubMed ID: 35721436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of ocular and nasopharyngeal microbiome in allergic rhinoconjunctivitis.
    Yau JW; Hou J; Tsui SKW; Leung TF; Cheng NS; Yam JC; Kam KW; Jhanji V; Hon KL
    Pediatr Allergy Immunol; 2019 Sep; 30(6):624-631. PubMed ID: 31132163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults.
    Hurst JH; McCumber AW; Aquino JN; Rodriguez J; Heston SM; Lugo DJ; Rotta AT; Turner NA; Pfeiffer TS; Gurley TC; Moody MA; Denny TN; Rawls JF; Clark JS; Woods CW; Kelly MS
    Clin Infect Dis; 2022 Aug; 75(1):e928-e937. PubMed ID: 35247047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.